BioSpace News Archive

Business

Evolva Provides 2017 Financial Results and Business Highlights

Evolva posted its financial results today for the period from 1 January to 31 December 2017, and provided business highlights that illustrate how the Company is executing on its strategic transformation plan which was put in place last August.

March 20, 2018
·
2 min read
Essity Publishes its Annual and Sustainability Report for 2017

Essity has today published its Annual and Sustainability Report for 2017, available on www.essity.com.

March 20, 2018
·
1 min read
Business

OncoSec Announces Strategic Relocation Of Office And Laboratories

Relocation Saves $65,000 Per Month and Eliminates $14 Million Long-Term Liability

March 20, 2018
·
4 min read
FDA

DURECT Announces FDA Advisory Committee Meeting for REMOXY® ER

DURECT Corporation (Nasdaq: DRRX) today announced that its licensee, Pain Therapeutics (Nasdaq: PTIE), reported yesterday that the U.S. Food and Drug Administration (FDA) will hold an Advisory Committee Meeting to discuss the New Drug Application (NDA) for REMOXY ER (extended release oxycodone CII).

March 20, 2018
·
5 min read
Business

Motus GI Announces Issuance of European Patent for the Pure-Vu® System

EU patent bolsters the Company’s IP portfolio for future expansion opportunity into European market where 6 million colonoscopies are performed annually

March 20, 2018
·
3 min read
Business

Arcadia Biosciences Welcomes New Chief Commercial Officer

Experienced Executive Will Strengthen Capabilities to Bring High-Value Health and Nutrition Ingredients to Market

March 20, 2018
·
3 min read
Genetown

Ongoing Assessment of Fluid Responsiveness Improves Clinical Outcomes in Septic Patients

Data leveraging Cheetah technology to be presented at the International Symposium on Intensive Care and Emergency Medicine in Brussels

March 20, 2018
·
3 min read
Deals

Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome

Cipher Pharmaceuticals and Cardiome Pharma Corp. announced their entry into a definitive arrangement agreement pursuant to which Cipher will acquire the Canadian business portfolio of Cardiome.

March 20, 2018
·
8 min read
Genetown

Nexcelom Bioscience announces strategic growth investment from Ampersand Capital Partners

Nexcelom Bioscience, a leading provider of cell counting and analysis products for biomedical research and the biopharma industry, announced today that it has received a strategic investment from Ampersand Capital Partners.

March 20, 2018
·
3 min read
Pharm Country

Mylan Adds to Growing Oncology Portfolio with Launch of Generic Mutamycin® Injection

Mitomycin for Injection is available to Mylan’s hospital and other institutional customers.

March 20, 2018
·
3 min read